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Abstract: Commercial mineral trioxide aggregate (MTA) materials such as Endocem MTA (EC), Dia-
Root Bio MTA (DR), RetroMTA (RM), and ProRoot MTA (PR) are increasingly used as root-end filling
materials. The aim of this study was to assess and compare the physicochemical and mechanical
properties and cytotoxicity of these MTAs. The film thicknesses of EC and DR were considerably less
than that of PR; however, RM’s film thickness was greater than that of PR. In addition, the setting
times of EC, DR, and RM were shorter than that of PR (p < 0.05). The solubility was not significantly
different among all groups. The three relatively new MTA groups (EC, DR, and RM) exhibited a
significant difference in pH variation and calcium ion release relative to the PR group (p < 0.05). The
radiopacity of the three new MTAs was considerably less than that of PR. The mechanical strength of
RM was not significantly different from that of PR (p > 0.05); however, the EC and DR groups were
not as strong as PR (p < 0.05). All MTA groups revealed cytocompatibility. In conclusion, the results
of this study confirmed that EC, RM, DR, and PR exhibit clinically acceptable physicochemical and
mechanical properties and cell cytotoxicity.
Keywords: mineral trioxide aggregate (MTA); root-end filling materials; endodontic materials;
retrograde filling materials
1. Introduction
Calcium silicate-based cements (CSCs) have various indications for use in endodontics,
and their clinical applications have increased over the years. Mineral trioxide aggregate
(MTA) is a calcium silicate-based material commonly considered ideal for endodontic
treatment due to its excellent biological and physicochemical properties [1–4]. The first
commercially available MTA, Pro Root MTA (Dentsply, Tulsa, OK, USA), is composed of
Portland cement and bismuth oxide [5,6].
MTA is recommended for a number of clinical applications in endodontic treatment,
such as pulp capping, pulpotomy, apexification, apicogenesis, apical barrier, repair of root
perforations, formation in teeth with necrotic pulps and open apexes, root-end filling, and
orthograde root canal filling [1,4]. An ideal endodontic repair material should be biocom-
patible, easy to handle, insoluble in body fluids, economical, and dimensionally stable for
long-term clinical success [1,4]. MTA has several advantages in terms of biocompatibility,
bioactivity, sealing ability, and dimensional stability [7,8].
Conventional MTA, ProRoot MTA (PR), has supplanted other endodontic materials
because of its superior physico-chemical and biological properties that are due to its com-
position of fine hydrophilic powders of tricalcium silicate, tricalcium aluminate, tricalcium
oxide, and other oxides [1,4,9]. Although it has a variety of favorable properties, conven-
tional MTA (PR) has been reported to have several drawbacks in clinical settings because of
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its long setting time, expense, sensitivity to the presence of moisture, and low compressive
strength compared with other endodontic treatments [1,4,10–13]. Since, PR sets relatively
slowly, it may be washed out from the preparation under hemorrhagic conditions when
it is used as a root-end filling material, which may cause treatment failure [1,9]. PR also
has a discoloration potential, which can contribute to tooth discoloration, discoloration
and it contains a variety of toxic elements. It is important to overcome conventional MTA’s
biocompatibility drawbacks [1,9,14].
Recently, a new type of silicate-based MTA (Endocem MTA, Retro MTA, and Diaroot
BioMTA) was developed to overcome these disadvantages when used as an endodontic
treatment [7,15,16]. Endocem MTA (EC) contains fine particles of pozzolan, a calcium
silicate-based material that reacts with calcium hydroxide (formed after a hydration re-
action) and produces additional cementitious materials. EC has been reported to show
biocompatibility similar to MTA, improve washout resistance, and cause less tooth discol-
oration [7,9,17]. Retro MTA (RM) was recently developed and introduced to the market as a
new hydraulic calcium silicate-based material proposed for use in endodontic applications
similar to those of MTA [18]. RM is a fast-setting MTA that consists of a calcium zirconia
complex. According to the manufacturers, RM has less discoloration potential, is relatively
cost-effective, and is easy to manipulate. Recently, a study showed that RM has similar
biocompatibility to PR [15,16,19–23]. Dia Root Bio MTA (DR) is a newly improved calcium
silicate-based MTA that is easy to manipulate and promotes cementogenesis and sealing
capability inside the root canal system. However, only a limited amount of information is
available on this product. Despite the increase in the use of MTA as an endodontic treat-
ment material, there has been limited information on these new products in the previous
literature [16].
A review of previous studies revealed no direct comparisons of these three commercial
MTAs with PR. Thus, the purpose of this study was to assess and compare the physico-
chemical, mechanical properties, and cytotoxicity of these three new types of MTA with
Pro Root MTA as a retrograde filling material. In the present study, we compared the three
commercial MTAs with Pro Root MTA in terms of setting time, film thickness, solubility,
radiopacity, pH, the release of calcium ions, compressive strength, and cytotoxicity.
The null hypotheses of this study were; (1) There will be no significant differences in
the physicochemical properties between any of the three new MTAs in comparison to PR,
(2) There will be no significant differences in the mechanical properties between any of the
three new MTAs in comparison to PR, (3) There will be no significant differences in the
cytotoxicity between any of the three new MTAs in comparison to PR.
2. Materials and Methods
2.1. Materials and Preparation of the Specimens
Four commercially available MTAs were used in the present study (Table 1). Endo-cem
MTA (EC) was mixed with sterile normal saline at a W/P ratio of 0.12 cc:300 mg, Dia-Root
Bio MTA (DR) was mixed with sterile distilled water at a W/P ratio of 0.225 g:0.5 g, Retro
MTA (RM) was mixed with provided liquid at a W/P ratio of 3 drops:0.3 g, and Pro Root
MTA (PR) was mixed with provided liquid at a W/P ratio of 3:1 as recommended instruc-
tions by the manufacturer. In addition, sterile normal saline (Cleancle, JW Pharmaceutical
Co., Seoul, Korea) and sterile distilled water (sterilized distilled water for intermediate
and external perfusion, JW Pharmaceutical Co., Seoul, Korea) were used to mix EC and
DR, respectively.
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2.2. Film Thickness, Setting Time, and Solubility
The film thickness, setting time and solubility tests of the materials were measured
based on the International Organization for Standardization (ISO) 6876 standard methods.
To investigate the film thickness, two flat glass plates with 25 mm square (contact surface
area of approximately 625 ± 50 mm2) were combined to measure the thickness of the
two glass plates in contact. Three minutes after starting the mixing, a load of 150 N was
applied vertically on the upper plate. Ten minutes after the start of mixing, the thickness
to an accuracy of 1 µm of the space between the two glass plates that was filled with
experimental material was measured using a digital caliper (Mitutoyo Model CD-15CPX;
Mitutoyo Co., Kawasaki, Japan). The test was repeated 3 times for each group.
To analyze the setting time, the initial and final setting times were measured by eval-
uating the absence of indentations caused by Gillmore needles. The mixed experimental
material was filled into a mold with internal diameter of 20 mm and height of 2 mm.
Before the test, all the apparatus was conditioned for 24 h under 100% relative humidity at
37 ± 1 ◦C. The setting time test was performed under 100% relative humidity at a tempera-
ture of 37 ± 1 ◦C using the Gillmore needle. Each of the two indenters with flat ends and a
mass of 100 ± 0.5 g (initial setting time) or 453.6 g (final setting time) were loaded vertically
onto the top surface of the specimens. The test was repeated 3 times for each group.
To measure the solubility, the mixed experimental material was placed in a mold with
20 mm diameter and 2 mm height, and the excess was removed. The filled mold was placed
under 100% relative humidity at 37 ± 1 ◦C for 7 d. For each tested experimental material,
two specimens were used (total 6, n = 3). The initial mass of the two specimens (m0) and
the container (M0) were measured to the nearest 0.001 g by an analytical balance (XS105,
Mettlertoledo AG, Greifensee, Switzerland). The two specimens were immersed in 50 mL
distilled water and placed in a water bath maintained at 37 ± 1 ◦C for 24 h. After 24 h, the
specimen was removed from the container, washed with distilled water, and then placed
in an oven at 80 ± 2 ◦C for drying. Subsequently, the desiccator was cooled and weighed
to determine the final mass (M1). The final mass of each specimen was deter-mined, and
the loss of mass was calculated by the following equation:
Solubility (%) = 100 × (M1 − M0)/m0
2.3. Radiopacity
Radiopacity evaluation of the set materials was performed using the ISO 6876 and
13116. Each mixed MTA material was filled into a mold 10.0 ± 1.0 mm in diameter and
1.0 ± 0.1 mm height. To obtain the radiographic images, both specimens and an aluminum
step wedge were placed on a digital sensor and exposed to an X-ray unit (Carestream
CS7600, Siemens, Munich, Germany) at 65 ± 5 kV and 10 mA with a 300 ± 100 mm
focus-film distance. The grey pixel values of each specimen were determined using the
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Photoshop program (Adobe, San Jose, CA, USA), and the equivalent radiopacity of the
cement sample was calculated in mm of aluminum (Al mm).
2.4. Compressive Strength at 7 Days
Each MTA materials was mixed and filled into a mold 4 mm in diameter and 8 mm
in height. Seven cylindrical samples for each group were prepared. The specimens were
incubated under 100% relative humidity at a temperature of 37 ± 1 ◦C. The specimens for
compressive strength were ground with a wet 600 grit 7 d after preparation. A computer-
controlled universal testing machine (Model 3366; Instron®, Norwood, MA, USA) was
used to compress the specimens. The compressive strength was measured at a crosshead
speed of 0.25 mm/min.
The maximum load of the compressive strength was recorded and calculated in
MPa as:
CS = 4P/πD2
where CS is the compressive strength, p is the maximum force applied in Newtons (N), and
D is the mean diameter of the specimen in millimeters (mm).
2.5. pH, Calcium Ion Release, and Bioactivity
To analyze the pH variation of the soaking solution and calcium ion release, each MTA
material was prepared and filled into a mold with an internal diameter of 10 mm and a
height of 1 mm. After filling, the specimen was stored at 37 ± 1 ◦C for 24 h. The specimen
was separated from the mold and was then immersed in 10 mL of Hank’s balanced salt
solution (HBSS; H6648, Sigma Aldrich, St. Louis, MO, USA) [24]. A pH meter (Orion 4 Star,
Thermo Fisher Scientific Inc., Singapore) calibrated using buffer solutions of pH 4.01, 7.00,
and 10.01 was used. The pH variation of the HBSS-immersed specimen was measured at
3 h, 6 h, 24 h, 72 h, and 168 h.
The same solutions used to test the pH variation were used to test for calcium ion
release. After 168 h, to analyze calcium ion release from the specimens, the HBSS was
filtered with a 0.22-µm syringe filter (DISMIC 25CS, Advantec, Osaka, Japan) and subjected
to inductively coupled plasma optical emission spectrometry (ICP-OES, Optima 8300,
PerkinElmer, Waltham, MA, USA). The measurements of the pH and calcium ion release
were repeated 3 times, and mean and standard deviations were used.
The morphology of the specimens before and after immersion in HBSS solution was
analyzed by field emission scanning electron microscopy (FE-SEM, MERLIN, Carl Zeiss,
Oberkochen, Germany) after ion sputtering (Leica EM ACE600) to coat the specimen
with platinum.
2.6. Cell Viability
Mouse fibroblast cells (L929; CRL-6364; ATCC, Manassas, VA, USA) were cultured in
RPMI 1640 (Welgene, Daegu, Korea) supplemented with 10% fetal bovine serum and 1%
antibiotics under standard cell culture conditions (37 ◦C, 100% humidity, 95% air, 5% CO2).
L929 cells were seeded in a 96-well plate at a density of 1 × 104 cells/well and incubated
for 24 h under standard cell culture conditions.
The specimen of each MTA material was formed under aseptic conditions in a sterile
cylindrical mold 5 mm in diameter and 2 mm high and sterilized using ultraviolet irradia-
tion (UV) for 30 min before storage in an incubator at 37 ± 1 ◦C for 24 h to achieve complete
setting. The ratio of material surface area to medium volume was set at approximately
3 cm2/mL in accordance with the ISO 10993-5 and 12 [25,26].
The extraction medium was filtered through a 0.22 µm syringe filter, and three con-
centrations (50%, 25%, and 12.5%) were prepared and applied to the cells. At 24 h, the
cytotoxicity was determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; Sigma-Aldrich, St. Louis, MO, USA) assay. MTT solution was added to the
cells and incubated at 37 ◦C for 2 h in the dark. The MTT solution was then removed, and
100 µL of dimethyl sulfoxide (0231, VWR Life Science, Radnor, PA, USA) was added to
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each well. The optical density (OD) at 570 nm was measured using a plate reader (Epoch,
BioTek, Winooski, VT, USA). The experiments were performed in triplicate.
2.7. Statistical Analysis
The results of film thickness, setting time, solubility, radiopacity, compressive strength,
pH variation, calcium ion release, and cell viability were analyzed using the SPSS 25
software program (IBM Corp., Armonk, NY, USA). To calculate the mean and standard
deviation (SD), descriptive statistics was conducted. In addition, to analyze the significant
difference among the MTA groups, one-way analysis of variance (ANOVA) and Tukey’s
honest significant difference (HSD) test were performed. p-vales less than 0.05 were
considered statistically significant.
3. Results
3.1. Film Thickness, Setting Time, and Solubility
Table 2 shows the means, standard deviations, and statistical comparisons of the film
thickness, setting time, and solubility tests of the commercial materials studied.
Table 2. Means ± standard deviation (SD) for film thickness, setting time, solubility, and compressive strength.
Materials




EC 0.28 ± 0.16 a 4.45 ± 0.05 b 16.60 ± 1.15 b 8.11 ± 11.40 a 20.33 ± 12.54 b
DR 0.26 ± 0.07 a 27.24 ± 0.88 d 49.31 ± 2.60 c 2.23 ± 0.33 a 20.64 ± 9.25 b
RM 0.96 ± 0.18 c 3.05 ± 0.05 a 4.43 ± 0.12 a 0.89 ± 0.31 a 65.69 ± 27.26 a
PR 0.58 ± 0.05 b 18.53 ± 0.42 c 122.67 ± 6.43 d 0.82 ± 0.34 a 68.21 ± 16.22 a
Different lowercase superscript letters indicate statistically significant differences between MTA groups (p < 0.05).
The mean film thickness values of EC, DR, RM, and PR were 0.28, 0.26, 0.96, and
0.58 mm, respectively. RM had the thickest film, and EC and DR had the thinnest films
among the tested groups (p < 0.05).
Regarding initial setting times, RM had the shortest initial setting time, and DR had
the longest setting time (p < 0.05). Additionally, RM had the shortest final setting time, and
PR had the longest final setting time (p < 0.05). RM presented the lowest mean final setting
time values among the materials tested (p < 0.05), followed by EC, DR, and PR (p < 0.05).
For the results of the solubility test, no significant differences were observed among
the evaluated materials (p > 0.05). EC showed the highest value over 3% (8.11%).
3.2. pH Variation, Calcium Ion Release, and Bioactivity
The means, standard deviations, and statistical comparisons for pH and calcium ion
release (mg/L) are shown in Table 3. The pH values measured for DR were slightly higher
at all time points. PR had a lower pH value than the other groups during the initial period
(3, 6, and 24 h). After 72 h, all of the materials had similar pH values, except for EC, which
showed lower pH values (p < 0.05). DR and RM had the highest pH, followed by PR and
EC, at 168 h (p < 0.05). Only RM showed a statistically significant difference in relation to
the interaction between the storage solution and materials at all times (p < 0.05). There was
no significant difference between the pH values obtained for all groups at 168 h immersion
time (p > 0.05).
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Table 3. pH variation and calcium ion release (mg/L) in soaking solution for 7 days.
Materials
pH and Calcium Release in Soaking Water (Means ± SD)
3 h 6 h 24 h 72 h 168 h
Ca Ions
Concentration
at 7 Days (mg/L)
EC 11.58 ± 0.01 ABab 11.63 ± 0.07 ABab 11.28 ± 0.05 Cb 11.49 ± 0.08 Bb 11.70 ± 0.01 Ac 76.33 ± 2.93 c
DR 12.13 ± 0.10 BCa 12.30 ± 0.06 ABa 12.07 ± 0.07 Ca 12.19 ± 0.05 ABCa 12.33 ± 0.07 Aa 377.34 ± 52.19 a
RM 11.09 ± 0.09 Eab 11.28 ± 0.04 Dbc 11.85 ± 0.09 Ca 12.13 ± 0.01 Ba 12.38 ± 0.05 Aa 346.78 ± 92.14 ab
PR 10.20 ± 0.48 Cb 10.66 ± 0.65 BCc 11.42 ± 0.17 ABb 12.01 ± 0.30 ACa 11.97 ± 0.06 Ab 215.16 ± 62.25 cb
Different uppercase superscript letters indicate statistically significant differences between immersion times (p < 0.05, in the same line).
Different lowercase superscript letters indicate statistically significant differences between MTA groups (p < 0.05, in the same column).
With regard to the release of calcium ions, all materials released considerable amounts
at 7 days. Additionally, the results of the ICP-OES analysis showed that RM and PR had
significantly more calcium release than EC and DR (p < 0.05).
The morphology of the surfaces formed after the pH test of each of the samples can be
assessed using the SEM images presented in Figure 1. SEM analysis revealed the presence of
precipitates with various morphologies (Figure 1). All specimens had prismatic, hexagonal,
cubical, needle-like, globular-like, petal-like, and scale-like crystalline precipitates on their
surface (Figure 1A–D), which were not revealed in specimens that had not been immersed
in HBSS (Figure 1E–H).
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Figure 2. The radiopacity of the specimens was expressed as the equivalent thickness of aluminum
( m Al), and radiographic images of the specimens were obtained. The same lowercase letters
indicate s atistically significant diff rences (p < .05).
3.4. Compressive Strength at 7 Days
After 7 d of setting, the specimens were tested for compressive strength (MPa). The
results for the mechanical properties of the specimens are presented in Table 2. Over-
all, the compressive strength values of PR (mean = 62.70 ± 15.92 MPa) and RM (mean =
77.48 ± 22.49 MPa) were significantly greater than those of EC (mean = 18.51 ± 9.18 MPa,
p < 0.05) and DR (mean = 23.45 ± 9.65 MPa, p < 0.05). PR was not significantly different
in compressive strength from RM (p > 0.05), and EC was not significantly different in
compressive strength from DR (p > 0.05).
3.5. Cell Cytotoxicity
The cell cytotoxicity of the extract from four MTA specimens at different extract
concentrations is shown in Figure 3. The cells cultured on MTA eluates for 24 h were
measured by MTT assays, considering cells cultured in the absence of the specimen extract
as a blank control. When all specimen extract concentrations were diluted to 50%, an effect
on fibroblast cell cytotoxicity was detected (below 70%), and when the extract concentration
was diluted to 25% or lower, no effect on cell viability was shown (above 70%). EC eluents,
diluted 50%, exhibited higher cell viability than the other MTA groups (p < 0.05). The
viability of cells treated with EC, RM, and PR was similar in the 25 and 12.5% diluted
extracts (p > 0.05). The viability of cells treated with DR was significantly lower than those
treated with PR in 25 and 12.5% diluted extracts (p < 0.05), whereas there was no significant
difference in cell vi bility compared with EC and RM (p > 0.05). Additionally, for DR,
cells incubated in 12.5% diluted extract had sig ificantly lower cell viability than cells
incubated at the same extract concentrations of the other groups (p < 0.05). Cell viability was
significantly affect d in he pr sence of a diluti n factor between 50% and 25% (p < 0.05);
however, there was o significant difference between 25% a d 12.5% (p < 0.05). For all
MTA groups, significant differences w re detect d betwee the 50 and 25% dilutions
(p < 0.05). A expe ted, extract dilution in medium decr ased MTA cytotoxicity.
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4. Discussion
When nonsurgical endodontic treatment fails or ca not be performed, surgical r ot
canal treatment should be conducted. This surgical procedure includes the placement
of a retrograde filling m terial in close contact with the peri-radicular tissu . Therefore,
the physical and chemical properties as well as the biocompatibility of the retrograde
filling material are very important for the success of apical surgery [26]. Generally, MTA
is considered the gold standard material in clinical applications. Several previous studies
found that MTA as a root-end filling material had excellent physicochemical properties
and demonstrated its supremacy over other commonly used materials [26–28].
Recently, several new TA-based endodontic treatment materials were introduced to
improve clinical practice [9,13,17,29–31]. We evaluated the physicochemical and mechan-
ical properties and cell cytotoxicity of three new commercial MTAs in comparison with
conventional MTA (PR).
The physical properties of MTA, such as setting time, film thickness, and solubility,
strongly affect the material’s clinical performance. In particular, these properties are
important clinical factors affecting their sealing ability. For instance, the thicker the film,
the lower the chance of material penetration into the accessory root canal system [32].
Several previous works reported that a thinner layer of sealer positively affected the sealing
ability of the root canal filling [33–35]. In this study, the results showed that all MTA groups
had a thinner film than PR (p < 0.05), except for RM (p > 0.05).
A long setting time of materials provides an adequate working time when performing
surgical treatment, such as retrograde filling or perforation repairs. However, in certain
clinical situations, such as apexification and particularly apical surgery, unset material
may be washed out by body fluid and/or blood in the surgical field, which may lead to
treatment failure and cytotoxicity [36–39].
A fast setting time for materials ensures that the MTA has the least amount of interac-
tion time with the contaminants present in the oral cavity, making it easier to place a second
restorative material on top of the MTA [36,40,41]. The MTA setting time could be a factor
that is directly related to surgical root canal treatment success [39]. Hence, in some clinical
conditions, an accelerated setting time is required to avoid dissolution of the materials
under oral conditions [36]. The results of this study confirmed that the final setting time
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of the three new MTAs was shorter than that of PR (p < 0.05). A previous study reported
that the proper setting time is considered to be 10 and 15 min in clinical situations [36].
This result is in agreement with a previous setting time test and indicates that both EC and
RM had the proper setting time [7,15,16,18]. The main advantage of RM over PR includes
its reduced setting time because of the fast setting of its calcium silicate-based materials,
which form calcium zirconia complexes [15,16]. The EC group sets quickly without the
addition of a chemical accelerator because it contains fine-particle pozzolan cement [6,42].
Solubility is an acceptable property for endodontic treatment materials, since it allows
the release of ions. However, it is important that excess solubilization of the material does
not occur [43]. Most endodontic failures occur as a result of the leakage of irritants from
pathologically involved root canals into the periapical tissues [44]. Hence, endodontic
and restorative materials should also have a long-term seal and prevent leakage from the
oral cavity and/or the periapical tissue [45]. To provide long-term stability and prevent
microleakage from the periapical tissue, root-end filling material must have a low solu-
bility [44]. Thus, a low solubility in distilled water, as proposed in the Standard of the
International Standard Organization (ISO) 6876, is required [46]. Following this test, the
weight loss of each specimen is indicated as the percentage of the original mass, and the
ideal recommendation is a value less than 3% [45,46].
Radiopacity is a very important characteristic required for pulp treatment materi-
als [47]. Root-end filling and endodontic repair materials must have radiopacity to allow for
evaluation of the quality of the filling for patient safety. A radiopaque material is essential
to identify the location of the material in the root canal and to allow for filling failures to be
corrected before final restoration [48]. MTA with a radiopacity value lower than 3 mm Al is
hardly distinguishable from dentine. Clinically acceptable values of radiopacity, i.e., higher
than 3 mm Al, are mandatory for controlling the quality of root canal filling [43,49]. In the
present study, all MTA groups achieved the minimum required radiopacity value of 3 mm
of Al, as recommended by the ISO 6876 standard.
When MTA contacts fluids, it rapidly releases calcium and hydroxyl ions and creates
an alkaline pH on its external surface, leading to the nucleation and crystallization of
apatite on the material’s surface [50,51]. Numerous previous studies reported that MTA
has the ability to form calcium phosphate apatite crystals on its surface after contact
with phosphate-containing simulated body fluid solution [50–52]. Consequently, the
deposition of calcium and phosphate apatite into voids and spaces between the dentin,
root canal systems, and root filling material enables MTA to encourage regeneration and
remineralization of adjacent hard tissues while also improving its sealing capacity [50,53,54].
Thus, apatite-forming ability may provide clinical advantages by improving the sealing via
the deposition of apatite at the interface and inside the dentinal tubules of the root canal
when MTA is used as a root canal filling material [13,50,54]. HBSS solution was used in
the present study as a storage solution to simulate the clinical environment. In this study,
all materials showed alkalinizing activity and the formation of crystalline apatite on the
surface of the specimens.
MTA is a hydraulic cement consisting of fine hydrophilic particles that gradually
harden in a wet environment [11,55]. The compressive strength of MTA which was set
for 28 days is considered an indicator of the progression of the hydration reaction and a
reflection of the setting process. In this study, compressive strength of each sample was
measured following 7 days of storage. The number of days of storage was determined
in accordance to a draft of ISO 6876 that is currently under revision and in order to
compare MTA following adequate hydration. Still, the study is limited as the optimal
days of storage were not predetermined which would have resulted in a higher level of
compressive strength. In accordance with clinical perspectives, a greater compressive
strength of MTA is considered to be an important feature when this material is used as pulp
capping or as a coronal restorative material when it is submitted to occlusal and mastication
forces [56]. However, when MTA is used as a root-end filling material, where minimal
forces are applied, a low compressive strength will not be a major clinical drawback [40,57].
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Cell cytotoxicity of endodontic materials is of great concern because irritation of the
surrounding tissue can affect periapical tissue regeneration [22,58,59]. In an in vitro study,
after application in medium, MTA suffers a hydration reaction that results in the formation
of calcium hydroxide and subsequent ionic dissociation into calcium and hydroxyl ions,
which is responsible for an increase in pH value and an elevated calcium concentration in
the cell medium [60]. In this study, the four commercial MTAs maintained a cell viability
rate above 70% for all dilutions, except for the 50% diluted eluent. When comparing the
cell cytotoxicity of the four commercial MTAs in this study, PR resulted in the highest
cell viability, and DR was significantly more cytotoxic than the other two types (p < 0.05).
This cytotoxic effect of DR may be attributed to the differences in the initial amount of
various ions released from the materials. Additionally, another factor may be caused by
the characteristics of the DR material itself, which can increase the pH value. According to
the manufacturer, DR has a strong antibacterial effect with a high alkaline pH (above pH
12). However, the DR group achieved the minimum required recommendation of a 70%
relative cell viability rate, as recommended by the ISO 10993-5 standard.
In terms of the initial null hypotheses of this study, the hypothesis about their physic-
ochemical properties was partially accepted. When the PR group was compared with the
EC, DR, and RM groups, the results of this study showed statistically significant differences
in film thickness, setting time, pH variation, calcium ion release, and radiopacity (p < 0.05),
although no significant differences were found for the solubility (p > 0.05). However, their
solubility was not significantly different from that of the PR group (p > 0.05). The second
null hypothesis was partially rejected because the EC and DR groups revealed a significant
difference in compressive strength (p < 0.05) when compared to the PR group; however, the
RM group revealed no significant difference compared to PR (p > 0.05). Finally, when the
three new MTAs were compared with PR, the results of this study showed a statistically
significant difference in cell cytotoxicity for all dilutions (p < 0.05). Therefore, the third null
hypothesis was rejected.
This study has several limitations. This in vitro study could not sufficiently simulate
the clinical situation, which involves a complex and variable biomechanical environment.
Also, as stated earlier, some of the methods are based on ISO 6876 where clinical relevance
may be different between conventional root canal filling material and MTA. Thus, addi-
tional studies are needed for long-term and simulated clinical situation evaluations while
such limitations are also something that would be useful when considering revision of the
current version of ISO 6876.
5. Conclusions
In conclusion, the present study confirmed that EC, RM, and DR exhibit clinically
acceptable physicochemical and mechanical properties and cell cytotoxicity relative to
PR. Therefore, we confirmed that the EC, RM, and DR have the physicochemical and
biocompatible characteristics that could be alternatives to conventional MTA as a retrograde
filling material.
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